Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale

被引:0
作者
Amstutz, D. [1 ,2 ]
Sousa, M. [1 ,2 ]
Maradan-Gachet, M. E. [1 ,2 ]
Debove, I. [1 ]
Lhommee, E. [3 ]
Krack, P. [1 ]
机构
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
[3] Univ Grenoble, CHU Grenoble Alpes, Dept Neurorehabil, Grenoble, France
关键词
Parkinson's disease; Non-motor symptoms; Behavioural changes; Neuropsychiatric symptoms; IMPULSE CONTROL DISORDERS; SUBTHALAMIC NUCLEUS STIMULATION; DOPAMINE DYSREGULATION SYNDROME; DEEP BRAIN-STIMULATION; QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; NEUROPSYCHIATRIC SYMPTOMS; PREMORBID PERSONALITY; VISUAL HALLUCINATIONS; MINOR HALLUCINATIONS;
D O I
10.1016/j.neurol.2024.11.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. - Neuropsychiatric symptoms are highly prevalent in Parkinson's disease (PD) and significantly affect the quality of life of patients and their significant others. The aim of this work is to describe typical neuropsychiatric symptoms and their treatment. Methods. - This is a narrative opinion paper, illustrated by a fictional case report. The most common neuropsychiatric symptoms such as depressive symptoms, anxiety, apathy, psychotic symptoms, impulse control disorders, as well as cognitive impairment are discussed in the context of prodromal stage, early stage, fluctuations stage, post-surgical intervention, and late stage of PD. Results. - Multiple factors such as pathophysiology, dopaminergic medication, deep brain stimulation, personality traits and individual life circumstances influence neuropsychiatric symptoms. Since the complexity and causes of neuropsychiatric symptoms can change, management strategies have to be adapted and individualised throughout the disease trajectory. Discussion. - Recognising neuropsychiatric symptoms within the framework of the disease stage and identifying their potential causes is pivotal to provide adequate interventions. (c) 2024 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:265 / 283
页数:19
相关论文
共 205 条
[81]   What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them? [J].
Gallagher, David A. ;
Lees, Andrew J. ;
Schrag, Anette .
MOVEMENT DISORDERS, 2010, 25 (15) :2493-2500
[82]   A systematic practice review: Providing palliative care for people with Parkinson's disease and their caregivers [J].
Garon, Michela ;
Weck, Christiane ;
Rosqvist, Kristina ;
Odin, Per ;
Schrag, Anette ;
Krikmann, Uelle ;
Pedrosa, David J. ;
Antonini, Angelo ;
Lorenzl, Stefan ;
Martins Pereira, Sandra ;
Paal, Piret .
PALLIATIVE MEDICINE, 2024, 38 (01) :57-68
[83]   Incidence and management of idiopathic peri-lead edema (IPLE) following deep brain stimulation (DBS) surgery: Case series and review of the literature [J].
Giordano, Martina ;
Innocenti, Niccolo ;
Rizzi, Michele ;
Rinaldo, Sara ;
Nazzi, Vittoria ;
Eleopra, Roberto ;
Levi, Vincenzo .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 234
[84]   A CONTROLLED INVESTIGATION OF CURRENT AND PREMORBID PERSONALITY - CHARACTERISTICS OF PARKINSONS-DISEASE PATIENTS [J].
GLOSSER, G ;
CLARK, C ;
FREUNDLICH, B ;
KLINERKRENZEL, L ;
FLAHERTY, P ;
STERN, M .
MOVEMENT DISORDERS, 1995, 10 (02) :201-206
[85]  
Green S, 2021, npj Park Dis, V7, P1
[86]   A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis [J].
Grosset, D. ;
Taurah, L. ;
Burn, D. J. ;
MacMahon, D. ;
Forbes, A. ;
Turner, K. ;
Bowron, A. ;
Walker, R. ;
Findley, L. ;
Foster, O. ;
Patel, K. ;
Clough, C. ;
Castleton, B. ;
Smith, S. ;
Carey, G. ;
Murphy, T. ;
Hill, J. ;
Brechany, U. ;
McGee, P. ;
Reading, S. ;
Brand, G. ;
Kelly, L. ;
Breen, K. ;
Ford, S. ;
Baker, M. ;
Williams, A. ;
Hearne, J. ;
Qizilbash, N. ;
Chaudhuri, K. Ray .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (05) :465-469
[87]   Update of the MDS research criteria for prodromal Parkinson's disease [J].
Heinzel, Sebastian ;
Berg, Daniela ;
Gasser, Thomas ;
Chen, Honglei ;
Yao, Chun ;
Postuma, Ronald B. ;
Adler, Charles H. ;
Bloem, Bastiaan ;
Chan, Piu ;
Deuschl, Guenther ;
Dubois, Bruno ;
Goetz, Christopher G. ;
Halliday, Glenda M. ;
Hardy, John ;
Lang, Anthony E. ;
Litvan, Irene ;
Marek, Kenneth ;
Obeso, Jose ;
Oertel, Wolfgang ;
Olanow, C. Warren ;
Poewe, Werner ;
Stern, Matthew .
MOVEMENT DISORDERS, 2019, 34 (10) :1464-1470
[88]   Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial [J].
Henderson, Emily J. ;
Lord, Stephen R. ;
Brodie, Matthew A. ;
Gaunt, Daisy M. ;
Lawrence, Andrew D. ;
Close, Jacqueline C. T. ;
Whone, A. L. ;
Ben-Shlomo, Y. .
LANCET NEUROLOGY, 2016, 15 (03) :249-258
[89]   A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease [J].
Hernán, MA ;
Takkouche, B ;
Caamaño-Isorna, F ;
Gestal-Otero, JJ .
ANNALS OF NEUROLOGY, 2002, 52 (03) :276-284
[90]   Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications [J].
Hernandez-Con, Pilar ;
Lin, Iris ;
Mamikonyan, Eugenia ;
Deeb, Wissam ;
Feldman, Robert ;
Althouse, Andrew ;
Barmore, Ryan ;
Eisinger, Robert S. ;
Spindler, Meredith ;
Okun, Michael S. ;
Weintraub, Daniel ;
Chahine, Lana M. .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (06) :903-913